Jpmorgan Chase & CO Amneal Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,297,094 shares of AMRX stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,297,094
Previous 519,526
149.67%
Holding current value
$10.2 Million
Previous $3.3 Million
227.2%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AMRX
# of Institutions
184Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$171 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$115 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$96.8 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$88.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$84.2 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.19B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...